Valutazione comparativa di due metodi automatici per lo screening di Treponema pallidum

Submitted: 21 February 2014
Accepted: 21 February 2014
Published: 31 March 2007
Abstract Views: 760
PDF: 1556
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

In the present study we evaluated the performance of two automated chemiluminescence immunoassay for detection of Treponema pallidum antibodies in a routine laboratory approach. One hundred fifty samples, obtained from patients admitted to hospital with no signs or clinical history of syphilis were studied.All samples were tested for Treponema pallidum antibodies by the qualitative method Syphilis TP Architect (Abbott) and with DIASORIN Treponema Screen (DiaSorin) and the reactive results were confirmed by VDRL and IgM ELISA. Western blot IgG and IgM (AID GmbH),VDRL (Abbott) and EIAgen TMPA IgM (Adaltis) were used to analyze discrepant results. One hundred forty four samples had concordant result (96%) whereas six samples showed discordant results (negative with Architect and positive with DiaSorin).Among discordant tests, 5 positive results obtained with DiaSorin were confirmed by Western blot IgG, while one remained indeterminate. More and extensive evaluations may be useful to define Architect sensibility loss, with homogeneous cohorts of patients including those with a syphilis diagnosis, high risk subjects and patients with potential confounding factors like autoimmune diseases.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

How to Cite

Milano, F., Cianci, L., Pelagi, M., Pangaro, L., Olivieri, G., Verza, P., & Guazzotti, G. C. (2007). Valutazione comparativa di due metodi automatici per lo screening di Treponema pallidum. Microbiologia Medica, 22(1). https://doi.org/10.4081/mm.2007.2902